A collaborative disease management program for managing cholesterol in hospital patients

• Conditions: Hyperlipidaemia; Peripheral vascular disease; Blood - Other blood disorders; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system

• Registration Number: ACTRN12607000313437
• Lead Sponsor: Barwon Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-06-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients at Barwon Health who are undergoing treatment (medical and/or surgical) for PVD or those with limb artery disease; and2. With uncontrolled lipid profile (Total cholesterol >5.5mmol/L or LDL >3.5mmol/L after overnight fasting)

Exclusion Criteria

1. Minors/ patients who are unable to provide informed consent2. Patients who are already part of another compliance program or study3. Patients unwilling/unable for follow-up for six months.4. Patients having triglyceride levels >4mmol or other spurious lipid values.5. Patients with poor diabetes control, i.e HbA1c >6.5%.6. Patients having any hypersensitivity/ contraindication to lipid lowering drugs 7. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ipid levels[Measured in the two groups at baseline and end of study (6 months)];Patient adherence to treatment[Measured in the two groups at baseline and end of study (6 months)];Provider adherence to treatment guidelines[Measured in the two groups at baseline and end of study (6 months)]

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction with the service, economic benefits will be compared between the intervention and control group.[At the end of study (6months)]